Figure 1.

Estimated pitavastatin effect on COVID-19 outcomes. ^aCause-specific hazard ratio (HR) estimates with 95% CIs from Cox proportional hazards models for time to first event, stratified by Global Burden of Disease region. Deaths without COVID-19 were treated as competing events and censored. In the supporting analyses while on treatment, treatment discontinuations were also treated as competing events and censored. For visual purposes, the HRs with 95% CIs are shown in log scale on the x-axis. 100PY, 100 person-years; IR, incidence rate.